A New York Times analysis of federal data shows that deaths declined by 65% between late December and early February.
COVID-19 incidence and mortality has dropped significantly since the beginning of the effort to vaccinate nursing home residents and staff, according to a New York Times story today.
The newspaper’s analysis of federal data found that new cases among nursing home residents fell by 80% from late December through early February and that the deaths decreased by 65%.
Nursing homes were hit hard early on during the pandemic and through much of 2020. The Kaiser Family Foundation reported in November that the death toll of long-term care residents and staff had reached 100,000.
From the beginning of April through the end of July, deaths among nursing home residents and staff accounted for about 40.6% of all COVID-19-related deaths in the U.S.
That proportion was calculated by taking the foundation’s tally of 62,718 long-term care facility deaths as of July 2020 as a percentage of the John Hopkins Coronavirus Resource Center’s cumulative COVID-19 death total of 154,500 at the end of July 31, 2020.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
A Motor Neuron Mystery Points to New Potential SMA Treatment Targets
December 20th 2024Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has discovered that even in muscles that appeared resistant to SMA, subtle changes had occurred at the cellular level.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
A Motor Neuron Mystery Points to New Potential SMA Treatment Targets
December 20th 2024Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has discovered that even in muscles that appeared resistant to SMA, subtle changes had occurred at the cellular level.
Read More
2 Commerce Drive
Cranbury, NJ 08512